🔗 Permalink

Inventor profile of:

John Liddle

City:

Stevenage

Country:

United Kingdom

Published Applications:

Last publication date:

2022-09-22

Top Assignees for applications by John Liddle

The entities that hold a legal rights for patent applications filed by inventor Liddle John:

Glaxo Group Limited 10 Brentford, Middlesex, United Kingdom
Glaxo Group Limited 8 Greenford, United Kingdom
GLAXO GROUP LIMITED 8 Greenford, Middlesex, United Kingdom
Glaxo Group Limited 4 Brentford, United Kingdom
GlaxoSmithKline Intellectual Property Development Limited 3 Brentford, Middlesex, United Kingdom
The University Court of the University of Edinburgh 2 Edinburgh, United Kingdom
GlaxoSmithKline Intellectual Property Development Limited 2 Brentford, United Kingdom
DR. FALK PHARMA GMBH 1 Freiburg, Germany
SmithKline Beecham Corp. 1 Philadelphia, PA United States
Smithkline Beecham p.l.c. 1 , United Kingdom

Recent patent applications by Liddle John

John Liddle from Stevenage, GB has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-09-22

US20220298125A1

Chemistry; metallurgy

3-(5-CHLORO-2-OXOBENZO[D]OXAZOL-3(2H)-YL) PROPANOIC ACID DERIVATIVES AS KMO INHIBITORS

#2 | 2020-03-26

US20200095227A1

Chemistry; metallurgy

Benzoimidazole derivatives as PAD4 inhibitors

#3 | 2019-11-14

US20190345117A1

Chemistry; metallurgy

3-(5-chloro-2-oxobenzo[d]oxazol-3(2H)-yl) propanoic acid derivatives as KMO inhibitors

#4 | 2019-06-06

US20190169178A1

Chemistry; metallurgy

Method of treating pancreatitis using 1,4-benzoxazine derivatives

#5 | 2019-04-04

US20190100517A1

Chemistry; metallurgy

COMPOUNDS

#6 | 2018-10-18

US20180297983A1

Chemistry; metallurgy

Benzoimidazole derivatives as PAD4 inhibitors

#7 | 2018-06-21

US20180170921A1

Chemistry; metallurgy

3-(6-alkoxy-5-chlorobenzo[D]isoxazol-3-YL)propanoic acid useful as kynurenine monooxygenase inhibitors

#8 | 2018-06-21

US20180170920A1

Chemistry; metallurgy

3-(6-chloro-3-oxo-3,4-dihydro-(2H)-1,4-benzoxazin-4-yl) propanoic acid derivatives and their use as KMO inhibitors

#9 | 2018-06-14

US20180161316A1

Human necessities

2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors

#10 | 2017-12-07

US20170349577A1

Chemistry; metallurgy

3-(6-alkoxy-5-chlorobenzo[d]isoxazol-3-yl)propanoic acid useful as kynurenine monooxygenase inhibitors

#11 | 2017-05-04

US20170119750A1

Human necessities

2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors

#12 | 2016-12-08

US20160355505A1

Chemistry; metallurgy

NOVEL COMPOUNDS

#13 | 2016-03-17

US20160074413A1

Human necessities

Substituted diketopiperazines and their use as oxytocin antagonists

#14 | 2016-02-04

US20160030442A1

Human necessities

Compounds

#15 | 2016-01-14

US20160009716A1

Chemistry; metallurgy

2-(azaindol-2-yl) benz imidazoles as PAD4 inhibitors

#16 | 2015-06-25

US20150175600A1

Chemistry; metallurgy

2-(azaindol-2-yl)benzimidazoles as PAD4 inhibitors

#17 | 2015-06-18

US20150166508A1

Chemistry; metallurgy

Compounds

#18 | 2015-06-11

US20150157640A1

Human necessities

NOVEL COMPOUNDS

#19 | 2015-04-16

US20150105387A1

Chemistry; metallurgy

SUBSTITUTED DIKETOPIPERAZINES AND THEIR USE AS OXYTOCIN ANTAGONISTS

#20 | 2014-08-21

US20140235639A1

Chemistry; metallurgy

NOVEL COMPOUNDS

#21 | 2014-02-27

US20140058105A1

Chemistry; metallurgy

Substituted diketopiperazines and their use as oxytocin antagonists

#22 | 2014-01-02

US20140005188A1

Chemistry; metallurgy

PYRIDO[3,4-B]PYRAZINE DERIVATIVES AS SYK INHIBITORS

#23 | 2014-01-02

US20140005177A1

Chemistry; metallurgy

PYRIDINYL- AND PYRAZINYL-METHYLOXY-ARYL DERIVATIVES USEFUL AS INHIBITORS OF SPLEEN TYROSINE KINASE (SYK)

#24 | 2013-09-26

US20130253188A1

Chemistry; metallurgy

Compounds

#25 | 2013-05-23

US20130131338A1

Chemistry; metallurgy

Substituted diketopiperazines as oxytocin antagonists

#26 | 2013-04-25

US20130102783A1

Chemistry; metallurgy

SUBSTITUTED DIKETOPIPERAZINES AND THEIR USE AS OXYTOCIN ANTAGONISTS

#27 | 2013-02-14

US20130040984A1

Chemistry; metallurgy

7-(1H-pyrazol-4-yl)-1,6-naphthyridine compounds as Syk inhibitors

#28 | 2012-09-13

US20120232061A1

Chemistry; metallurgy

Compounds

#29 | 2012-08-09

US20120202811A1

Human necessities

NOVEL COMPOUNDS

#30 | 2012-01-05

US20120004229A1

Human necessities

Substituted diketopiperazines and their use as oxytocin antagonists

#31 | 2011-06-23

US20110152262A1

Human necessities

Compounds

#32 | 2010-12-02

US20100305127A1

Human necessities

Compounds

#33 | 2009-10-01

US20090247541A1

Human necessities

Novel compounds

#34 | 2009-07-23

US20090186867A1

Human necessities

Substituted diketopiperazines as oxytocin antagonists

#35 | 2008-07-24

US20080176891A1

Chemistry; metallurgy

NOVEL COMPOUNDS

#36 | 2008-06-19

US20080146606A1

Chemistry; metallurgy

NOVEL COMPOUNDS

#37 | 2007-11-01

US20070254888A1

Human necessities

Piperazinediones as oxytocin receptor antagonists

#38 | 2007-06-28

US20070149524A1

Human necessities

Substituted diketopiperazines and their use as oxytocin antagonists

#39 | 2005-07-07

US20050148572A1

Human necessities

Substituted diketopiperazines as oxytocin antagonists

#40 | 2005-01-27

US20050020832A1

Chemistry; metallurgy

Pyridone, pyridazone and triazone derivatives as lp-pla2 inhibitors

#41 | 2005-01-20

US20050014793A1

Chemistry; metallurgy

Pyridinone derivatives for treatment of atherosclerosis

InventorID:

91837 ⎘